05:37 PM EDT, 08/12/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on August 12, 2024, sold 11,500 shares in Cytokinetics ( CYTK ) for $634,455. Following the Form 4 filing with the SEC, Blum has control over a total of 403,578 shares of the company, with 399,412 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224022027/xslF345X03/form4.xml